Quadrant Capital Group LLC Maravai Lifesciences Holdings, Inc. Transaction History

Quadrant Capital Group LLC

$3 Billion
Q3 2025

A detailed history of Quadrant Capital Group LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 11,075 shares of MRVI stock, worth $40,313. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,075

Holding current value

$40,313

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$2.03 - $2.89 $22,482 - $32,006	11,075 New	11,075 $31,000
Q1 2025 May 13, 2025	BUY	$2.21 - $6.13 $9,421 - $26,132	4,263 Added 254.2%	5,940 $13,000
Q4 2024 Feb 12, 2025	SELL	$4.42 - $8.5 $8,574 - $16,490	-1,940 Reduced 53.64%	1,677 $9,000
Q3 2024 Nov 12, 2024	SELL	$6.84 - $9.73 $7,619 - $10,839	-1,114 Reduced 23.55%	3,617 $30,000
Q2 2024 Aug 12, 2024	SELL	$6.87 - $11.34 $1,401 - $2,313	-204 Reduced 4.13%	4,731 $33,000

Q1 2024 May 15, 2024	BUY	$5.11 - $8.76 $8,513 - $14,594	1,666 Added 50.96%	4,935 $42,000
Q4 2023 Feb 08, 2024	BUY	$4.7 - $9.87 $14 - $29	3 Added 0.09%	3,269 $21,000
Q3 2023 Nov 14, 2023	BUY	$9.14 - $12.85 $22,950 - $32,266	2,511 Added 332.58%	3,266 $32,000
Q2 2023 Aug 09, 2023	SELL	$12.09 - $15.0 $19,078 - $23,670	-1,578 Reduced 67.64%	755 $9,000
Q1 2023 May 11, 2023	BUY	$12.99 - $16.48 $21,927 - $27,818	1,688 Added 261.71%	2,333 $32,000
Q4 2022 Feb 10, 2023	BUY	$12.5 - $24.78 $5,362 - $10,630	429 Added 198.61%	645 $9,000
Q3 2022 Nov 10, 2022	BUY	$20.6 - $30.37 $4,449 - $6,559	216 New	216 $6,000
Q1 2022 May 06, 2022	SELL	$24.46 - $40.92 $97 - $163	-4 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$36.8 - $60.62 $147 - $242	4 New	4 $0

Others Institutions Holding MRVI

# of Institutions

182

Shares Held

132M

Call Options Held

688K

Put Options Held

11.6K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $479M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Maravai Lifesciences Holdings, Inc. Transaction History